Back to Search
DEAN MADAR, M.D.
M.D.
Clinical Pathology/Laboratory Medicine Physician
NPI: 1376756627Individual
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
ME 81692(FL)
Research & Publications (10)
Comparison of the oxidative folding of lysozyme at a high protein concentration using aromatic thiols versus glutathione.
PMID 19477205·J Biotechnol·2009
4-observational
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.
PMID 17276063·Bioorg Med Chem Lett·2007
7-preclinical
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
PMID 17064063·J Med Chem·2006
7-preclinical
Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes.
PMID 17034148·J Med Chem·2006
7-preclinical
Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements.
PMID 16890427·Bioorg Med Chem Lett·2006
7-preclinical
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
PMID 16768443·Biochemistry·2006
4-observational
Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.
PMID 16759095·J Med Chem·2006
7-preclinical
Potential drug targets and progress towards pharmacologic inhibition of hepatic glucose production.
PMID 12570714·Curr Med Chem·2003
6-review
Prospects for pharmacologic inhibition of hepatic glucose production.
PMID 12570713·Curr Med Chem·2003
6-review
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator.
PMID 10956206·J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2278 QUEENS WAY
NAPLES, FL 34112 - Phone
- (954) 654-0286
Quick Facts
- NPI
- 1376756627
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile